Doug Brunk is a San Diego-based award-winning reporter who began covering health care in 1991. Before joining the company, he wrote for the health sciences division of Columbia University and was an associate editor at Contemporary Long Term Care magazine when it won a Jesse H. Neal Award. His work has been syndicated by the Los Angeles Times and he is the author of two books related to the University of Kentucky Wildcats men's basketball program. Doug has a master’s degree in magazine journalism from the S.I. Newhouse School of Public Communications at Syracuse University. Follow him on Twitter @dougbrunk.
News
How Does Moderate to Severe Eczema Affect Growth in Children?
Children with moderate to severe disease have higher BMIs and shorter height than matched counterparts.
News
What’s ‘Tried and True’ in Atopic Dermatitis? An Expert Reflects
“With our revolutionary systemic and evolving topical therapies, we are in a new day of pediatric management,” Dr. Lawrence Eichenfield said.
News
Consensus Statement Aims to Guide Use of Low-Dose Oral Minoxidil for Hair Loss
The earliest time point at which LDOM should be expected to demonstrate efficacy is 3-6 months.
News
CDC Investigating Adverse Events Related to Counterfeit, Mishandled Botulinum Toxin
Reactions have included blurry vision, double vision, drooping eyelids, difficult swallowing or breathing, and other symptoms of botulism.
News
Mild Hidradenitis Suppurativa: Positive Results Reported for Topical Therapy
Currently, there are no approved therapies for milder HS, and the standard treatments that we apply in clinical practice are often inadequate,"...
News
Bimekizumab Under FDA Review for Hidradenitis Suppurativa
Bimekizumab-bkzx was first approved in the United States in October 2023 for the treatment of moderate to severe plaque psoriasis in adults who...
News
New Tool Helps Clinicians Detect Zoom Dysmorphia in Virtual Settings
Affected individuals may fear being misunderstood, judged, or ridiculed because of a perceived flaw in their appearance, Dr. George Kroumpouzos...
News
Is A Patient Getting Under Your Skin? A Dermatologist Shares Tips for Coping
Sometimes it’s best to resign from providing care to difficult patients, Dr. Jason Reichenberg said.
News
Expert Highlights Emerging Trends in Neuromodulators
One potential newcomer is ready-to-use liquid botulinum neurotoxin, which contains no human or animal-derived excipients.
News
Expert Shares Her Phased Approach to Caring for Patients with Delusional Infestation
“I often tell patients, ‘I will never give up on you if you will never give up on me,’ ” Dr. Jenny Murase said.
News
What Does Health Equity in Dermatology Look Like?
“If you are contributing to cases in textbooks, make sure you have a variety of different skin types so that individuals who are referring to the...
News
Think Beyond the ‘Go-Tos’ for Wart Management, Expert Advises
“Salicylic acid and cryotherapy don’t do enough for our patients,” said Jennifer Adams, MD.
News
Formulation of Sclerotherapy Agent Found Useful for Submental Fat Reduction
The intent-to-treat population included 51 subjects at four sites.
News
Approval of Spesolimab for Generalized Pustular Psoriasis Expanded
Spesolimab is an injectable antibody that blocks the IL-36 receptor, a key part of the pathway shown to be involved in the cause of GPP.
News
Lebrikizumab Found Effective for Atopic Dermatitis in Patients With Darker Skin Tones
Lebrikizumab is currently under review by the Food and Drug Administration for treatment of atopic dermatitis.